ETF Managers Group, LLC Imv Inc. Transaction History

ETF Managers Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.45 $17,691 - $45,808	-31,592 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.07 - $1.5 $7,078 - $9,922	6,615 Added 26.48%	31,592 $45,000
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.78 $6,136 - $8,953	-5,030 Reduced 16.76%	24,977 $31,000
Q3 2021 Nov 15, 2021	BUY	$1.35 - $2.16 $13,798 - $22,077	10,221 Added 51.66%	30,007 $50,000
Q2 2021 Aug 16, 2021	SELL	$2.12 - $3.24 $1,553 - $2,374	-733 Reduced 3.57%	19,786 $42,000
Q1 2021 May 17, 2021	SELL	$2.92 - $4.41 $33,968 - $51,301	-11,633 Reduced 36.18%	20,519 $63,000
Q4 2020 Feb 16, 2021	SELL	$2.9 - $4.4 $14,995 - $22,752	-5,171 Reduced 13.85%	32,152 $101,000
Q3 2020 Nov 16, 2020	BUY	$2.87 - $5.95 $107,117 - $222,071	37,323 New	37,323 $172,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.